Writing the summary…
The Guardian view on Burnham’s Brexit reset: overdue, but proceed with care | Editorial
Source: The Guardian
Original reporting
The Guardian: read the full reportFollow this story
Earlier reports and follow-ups on the same developing story.
Related stories
CNBC2 outlets
Apple releases HomeView smart home hub with screen as showcase for Siri AI
New products from Apple include the HomeView, an iPad-like device that acts as a hub for other smart home gadgets Apple on Tuesday began showing off a new round of smart home products, including an iPad-like device dubbed the HomeView, meant to hang on walls or perch on tabletops and act as a hub for other smart home devices. The HomeView device starts at $299 and will begin shipping next month. It will feature a 7in screen and face recognition, will help users control doorbells, thermostats and smart locks in a market where Apple has tinkered for a decade without major success. The device will also showcase Apple’s AI-upgraded Siri virtual assistant. Continue reading...
CNBC
Paul Tudor Jones says 2027 could be a really challenging year for the stock market
The billionaire investor said that corporate buybacks, along with mergers and acquisitions, that have been a tail wind for the bull market are about to turn.
CNBC
Michael Dell says AI needs safeguards and controls, and government has a role to play
Dell CEO Michael Dell says AI models need safeguards and controls, with companies and government both playing a role in safety.
CNBC
Meta shares rise for a second straight day as new AI model family impresses
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
CNBC
Social Security cost-of-living adjustment for 2027 may be above average. Some say it's not enough
The Social Security Administration is expected to announce the cost-of-living adjustment for 2027. Projections point to a higher-than-average increase.
CNBC
Walmart to cover some GLP-1s, inhalers and insulin for employees at no cost as it expands benefits
Walmart will offer Novo's Ozempic and Lilly's Mounjaro without charge for people with Type 2 diabetes after a new prior authorization.